(Q43202813)

English

Fenofibrate improves endothelial function in the brachial artery and forearm resistance arterioles of statin-treated Type 2 diabetic patients

scientific article published on 23 February 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

Fenofibrate improves endothelial function in the brachial artery and forearm resistance arterioles of statin-treated Type 2 diabetic patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

0 references

4

object named as

Gerald F Watts

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

Sandra J Hamilton

object named as

Sandra J Hamilton

1

1 reference

ORCID Public Data File 2021

author name string

Gerard T Chew

2

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

Timothy M E Davis

3

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

language of work or name

0 references

publication date

23 February 2010

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

Clinical Science

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

118

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

607-615

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis

1 reference

https://api.crossref.org/works/10.1042%2FCS20090568

21 January 2018

Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1042%2FCS20090568

21 January 2018

MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1042%2FCS20090568

21 January 2018

Effects of fenofibrate treatment on cardiovascular disease risk in 9,795 individuals with type 2 diabetes and various components of the metabolic syndrome: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study

1 reference

https://api.crossref.org/works/10.1042%2FCS20090568

21 January 2018

The clinical implications of endothelial dysfunction

1 reference

https://api.crossref.org/works/10.1042%2FCS20090568

21 January 2018

Effect of fenofibrate on brachial artery flow-mediated dilatation in type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1042%2FCS20090568

21 January 2018

Both fenofibrate and atorvastatin improve vascular reactivity in combined hyperlipidaemia (fenofibrate versus atorvastatin trial--FAT).

1 reference

https://api.crossref.org/works/10.1042%2FCS20090568

21 January 2018

Combined effect of coenzyme Q10 and fenofibrate on forearm microcirculatory function in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1042%2FCS20090568

21 January 2018

Additive beneficial effects of fenofibrate combined with atorvastatin in the treatment of combined hyperlipidemia

1 reference

https://api.crossref.org/works/10.1042%2FCS20090568

21 January 2018

Diagnosis and classification of diabetes mellitus

1 reference

https://api.crossref.org/works/10.1042%2FCS20090568

21 January 2018

Coenzyme Q(10) improves endothelial dysfunction of the brachial artery in Type II diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1042%2FCS20090568

21 January 2018

Vascular function of the peripheral circulation in patients with nephrosis.

1 reference

https://api.crossref.org/works/10.1042%2FCS20090568

21 January 2018

Acute effects of oral glibenclamide on blood pressure and forearm vascular resistance in diabetics.

1 reference

https://api.crossref.org/works/10.1042%2FCS20090568

21 January 2018

Atorvastatin lowers C-reactive protein and improves endothelium-dependent vasodilation in type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1042%2FCS20090568

21 January 2018

The effects of atorvastatin on endothelial function in diabetic patients and subjects at risk for type 2 diabetes

1 reference

https://api.crossref.org/works/10.1042%2FCS20090568

21 January 2018

Aggressive lipid lowering does not improve endothelial function in type 2 diabetes: the Diabetes Atorvastatin Lipid Intervention (DALI) Study: a randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1042%2FCS20090568

21 January 2018

Hemodynamic effects of fenofibrate and coenzyme Q10 in type 2 diabetic subjects with left ventricular diastolic dysfunction

1 reference

https://api.crossref.org/works/10.1042%2FCS20090568

21 January 2018

Ciprofibrate therapy improves endothelial function and reduces postprandial lipemia and oxidative stress in type 2 diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1042%2FCS20090568

21 January 2018

Gemfibrozil improves insulin sensitivity and flow-mediated vasodilatation in type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1042%2FCS20090568

21 January 2018

Long-term effects of fenofibrate on carotid intima-media thickness and augmentation index in subjects with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1042%2FCS20090568

21 January 2018

Increased activity of endogenous endothelin in patients with type II diabetes mellitus

1 reference

https://api.crossref.org/works/10.1042%2FCS20090568

21 January 2018

Plasma asymmetric dimethylarginine and coronary and peripheral endothelial dysfunction in hypertensive patients

1 reference

https://api.crossref.org/works/10.1042%2FCS20090568

21 January 2018

Effect of fenofibrate on adiponectin and inflammatory biomarkers in metabolic syndrome patients

1 reference

https://api.crossref.org/works/10.1042%2FCS20090568

21 January 2018

Peroxisome proliferator-activated receptor alpha agonists increase nitric oxide synthase expression in vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1042%2FCS20090568

21 January 2018

Peroxisome proliferator-activated receptor activators inhibit thrombin-induced endothelin-1 production in human vascular endothelial cells by inhibiting the activator protein-1 signaling pathway

1 reference

https://api.crossref.org/works/10.1042%2FCS20090568

21 January 2018

Fenofibrate decreases asymmetric dimethylarginine level in cultured endothelial cells by inhibiting NF-kappaB activity

1 reference

https://api.crossref.org/works/10.1042%2FCS20090568

21 January 2018

Atorvastatin and micronized fenofibrate alone and in combination in type 2 diabetes with combined hyperlipidemia

1 reference

https://api.crossref.org/works/10.1042%2FCS20090568

21 January 2018

Identifiers

10.1042/CS20090568

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43202813&oldid=1983675256"